Overview
PYXS market data
Price History
PYXS price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.28 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.31 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.97 – $5.55 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $184.4 · P/B 1.34.
Company News
8-K filing — Pyxis Oncology, Inc. (PYXS)SEC EDGAR · Jul 2, 2026, 8:20 PM
Leerink Partners Maintains Outperform on Pyxis Oncology, Lowers Price Target to $7Benzinga · Jul 2, 2026, 12:40 PM
Pyxis Oncology Commences ~$50M Offering Of 19.6M Common Shares At $2.551/ShareBenzinga · Jun 30, 2026, 11:45 AM
12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga · Jun 26, 2026, 5:10 PM
Pyxis Oncology shares are trading lower. The company reported Q1 financial results.Benzinga · May 14, 2026, 7:50 PM
Pyxis Oncology Q1 EPS $(0.37), InlineBenzinga · May 14, 2026, 11:16 AM